TTX-MC138-NODAGA-Cu64
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TTX-MC138-NODAGA-Cu64, covering 2025-01-28 to 2025-01-28. Get the full timeline:
Most recent: Clinical Trial Update: A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors [EARLY_Phase 1]